Feasibility of estimation of brain volume and 2-deoxy-2- 18F-fluoro-D-glucose metabolism using a novel automated image analysis method: Application in Alzheimer's disease

Hellenic Journal of Nuclear Medicine

Volumn 15, Issue 3, 2012, Pages

  Musiek, Erik S ^a   Saboury, Babak ^a   Mishra, Shipra ^a   Chen, Yufen ^b   Reddin, Janet S ^a   Newberg, Andrew B ^a   Udupa, Jayaram K ^a   Detre, John A ^a,b   Hofheinz, Frank ^c   Torigian, Drew ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

18F FDG; Alzheimer's disease; Metabolic volume; PET; ROVER; Whole brain metabolism

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG METABOLISM; FEASIBILITY STUDY; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; VOXEL BASED MORPHOMETRY;

AGED; ALGORITHMS; ALZHEIMER DISEASE; ARTIFICIAL INTELLIGENCE; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; ORGAN SIZE; PATTERN RECOGNITION, AUTOMATED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84871867082     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005; 32: 486-510. (Pubitemid 40591181)
2. Silverman DH, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. Jama, 2001; 286: 2120-7.
3. 18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage 1999; 9: 63-80.
4. Salmon E, Collette F, Degueldre C et al. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum Brain Mapp 2000; 10: 39-48. (Pubitemid 30252412)
5. Herholz K, Salmon E, Perani D et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-16.
6. Ishii K, Sasaki H, Kono AK et al. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur J Nucl Med Mol Imaging 2005; 32: 959-63. (Pubitemid 41205668)
7. Smith GS, de Leon MJ, George AE et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol 1992; 49: 1142-50.
8. Mosconi L, Tsui WH, De Santi S et al. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005; 64: 1860-7. (Pubitemid 40800698)
9. Jagust WJ, Bandy D, Chen K et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 2010; 6: 221-9.
10. Alavi A, Newberg AB, Souder E, Berlin JA. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 1993; 34: 1681-7. (Pubitemid 23295377)
11. Torigian DA, Chong E, Schuster S et al. Feasibility and utility of ROVER software for 3D quantitative image analysis of FDG-PET in patients with diffuse large B-cell lymphoma (DLBCL). J Nucl Med 2009; 50: 135.
12. 18F-FDG-PET/CT. Hell J Nucl Med 2011; 14: 8-14.
13. Hofheinz F, Potzsch C, Oehme L et al. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin 2011; 51(1): 9-16.
14. Musiek ES, Chen Y, Korczykowski M et al. Direct comparison of FDG-PET and ASL-MRI in Alzheimer's Disease. Alzheimer's and Demenia 2012; 8(1) 51-9.
15. Morris JC, Weintraub S, Chui HC et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006; 20: 210-6. (Pubitemid 44900933)
16. Udupa JK, Nyul LG, Ge Y, Grossman RI. Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1,000 studies. Acad Radiol 2001; 8: 1116-26. (Pubitemid 33032264)
17. Landau SM, Harvey D, Madison CM et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010; 75: 230-8.
18. Moonis G, Liu J, Udupa JK, Hackney DB. Estimation of tumor volume with fuzzy-connectedness segmentation of MR images. Am J Neuroradiol 2002; 23: 356-63. (Pubitemid 34241312)
19. Landau SM, Harvey D, Madison CM et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2011; 32(7): 1207-18.
20. Mosconi L, Tsui WH, Rusinek H et al. Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 2007; 34: 1467-79. (Pubitemid 47312590)
21. Chetelat G, Desgranges B, Landeau B et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008; 131: 60-71.
22. Li Y, Rinne JO, Mosconi L et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008; 35: 2169-81.
23. Klunk WE, Engler H, Nordberg A et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-19. (Pubitemid 38269583)
24. 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 2010; 51: 913-20.
25. Kumar A, Newberg A, Alavi A et al. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study. Proc Natl Acad Sci U S A 1993; 90: 7019-23. (Pubitemid 23222380)
26. Gur RE, Resnick SM, Alavi A et al. Regional brain function in schizophrenia. I. A positron emission tomography study. Arch Gen Psychiatry 1987; 44: 119-25. (Pubitemid 17006450)
27. Seo SW, Lee BI, Lee JD et al. Thyrotoxic autoimmune encephalopathy: a repeat positron emission tomography study. J Neurol Neurosurg Psychiatry 2003; 74: 504-6. (Pubitemid 36379377)